Subscribe to Search results

The health system of Northern Ireland was managed by the UK government through the Northern Ireland Office. They answered directly to the UK government and in general, policy and strategy was developed to mirror English policy decisions.

Published on:

The Blood Products Laboratory was transferred from NHS Blood and Transport to become a Department of Health owned limited company: Bioproducts Laboratory Holdings Ltd.

Published on:

Bain Capital purchased an 80% stake in Plasma Resources UK Ltd, meaning that Bioproducts Laboratory Ltd was no longer under full public control.

Published on:

Creat Group Corporation acquired Bio Products Laboratory Holdings Ltd, of which BPL Ltd was a wholly owned subsidiary.

Published on:

The Lord Provost of Edinburgh, Sir Louis Gumley, formed a committee to take over responsibility for the existing blood donation service in Scotland.

Published on:

By the outbreak of the War, small blood banks had been set up in Edinburgh and Glasgow

Published on:

The blood products unit set up on the site of the Edinburgh Royal Infirmary to produce dried plasma in support of the war effort was expanded to handle plasma fractionation.

Published on:

The blood products unit moved to a new site in Liberton. It was named the Protein Fractionation Centre and was specifically designed for the fractionation of plasma.

Published on:

The facilities for the Protein Fractionation Centre were completed.

Published on:

All funds for the Scottish Home and Health Department were provided centrally.

Published on:

The Common Services Agency took over responsibility for the Scottish National Blood Transfusion Association which thereafter was formally known as the Scottish National Blood Transfusion Service.

Published on:

A sub-committee of the Common Services Agency to be known as the Blood Transfusion Service Sub-Committee was established.

Published on:

The Advisory Committee on the NBTS was dealing with matters concerning England and Wales but the Scottish Home and Health Department, Welsh Office and DHSS Northern Ireland were represented by observers.

Published on:

The position of general manager was created - renamed national director in 1996 - and the national medical director (Professor Cash) became the national medical scientific director.

Published on:

The Northern Ireland Blood Transfusion Service was established as an independent special health and social care agency, with Dr Morris McClelland appointed as Director.

Published on:

In the early 1980s, Northern Ireland began sending plasma to Scotland for fractionation at the Protein Fractionation Centre.

Published on:

Dr Tony Napier commented on the disadvantages of the system of regional autonomy for blood transfusion centres, stating that if the focus was on obtaining self-sufficiency in England and Wales, then accountability and funding discussions should have taken place centrally.

Published on:

Dr Harold Gunson wrote a report which summarised the core functions performed by all regional transfusion centres (RTCs) and some of the functions performed to a greater or lesser degree by RTCs.

Published on:

Dr Entwistle stated that the Cambridge RTC had arrangements for a night porter who would telephone the on-call doctor, if services were required out of hours, who could authorise for blood to be issued to hospital blood banks.

Published on:

Dr Entwistle in his evidence stated that the Oxford RTC unlike other RTCs sent its plasma to the Plasma Fractionation Laboratory (PFL) in Oxford, instead of the Blood Products Laboratory (BPL), and PFL sent the fractionated products directly to the Oxford Haemophilia Centre.

Published on: